Haemonetics
192 hedge funds and large institutions have $1.78B invested in Haemonetics in 2014 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 66 increasing their positions, 66 reducing their positions, and 34 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 34
0% more repeat investments, than reductions
Existing positions increased: 66 | Existing positions reduced: 66
2% less funds holding
Funds holding: 195 → 192 (-3)
1.6% less ownership
Funds ownership: 107.02% → 105.42% (-1.6%)
23% less capital invested
Capital invested by funds: $2.32B → $1.78B (-$540M)
70% less call options, than puts
Call options by funds: $411K | Put options by funds: $1.38M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Barrow, Hanley, Mewhinney & Strauss
Dallas,
Texas
|
+$79.7M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$56.6M |
| 3 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$45.9M |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.4M |
| 5 |
PIM
Perkins Investment Management
Chicago,
Illinois
|
+$17.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$106M |
| 2 |
Kayne Anderson Rudnick Investment Management
Los Angeles,
California
|
-$86.8M |
| 3 |
Capital World Investors
Los Angeles,
California
|
-$86.6M |
| 4 |
KI
Kalmar Investments
Greenville,
Delaware
|
-$41.8M |
| 5 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$21.6M |
HAE Hedge Fund Activity: Q1 2014 in Review
192 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2014, worth a combined $1.78B — down 23% from $2.32B a quarter earlier.
Fund positioning in HAE was balanced in Q1 2014: 34 funds opened new positions, 34 closed out, 66 added to existing stakes and 66 trimmed.
The largest buyer was Barrow, Hanley, Mewhinney & Strauss, adding an estimated $79.7M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $106M sold.
- 192 institutional investors held Haemonetics (HAE) as of Q1 2014, down from 195 in Q4 2013.
- Funds reported $1.78B of Haemonetics stock for Q1 2014, down 23% quarter-over-quarter.
- 34 funds opened new Haemonetics positions in Q1 2014 and 34 closed out, a net change of 0 holders.
- The largest Haemonetics buyer in Q1 2014 was Barrow, Hanley, Mewhinney & Strauss, an estimated $79.7M added.
- The largest Haemonetics seller in Q1 2014 was TimesSquare Capital Management, an estimated $106M sold.
Based on aggregated 13F filings for Q1 2014.